Julie Cosgrove

Head of Strategy & Operations US Market Access Sanofi

Commercial leader focused on building and scaling specialty and rare disease brands by connecting marketing, Market Access, and patient strategy. Over the past 20+ years, I've led launches, built high-performing teams, and driven growth across global and US roles in biotech and large pharma. My experience spans immunology, neurology, oncology, transplant, and metabolic disease, with deep expertise in HCP engagement, patient strategy, and omnichannel execution. What differentiates my approach is the ability to operate across the full commercial ecosystem, aligning brand strategy, access, and field execution to deliver measurable results. Most recently, I've led strategy and operations for US Market Access, driving organizational transformation and building scalable capabilities to improve performance and decision-making. I'm energized by high-growth environments and the opportunity to help companies successfully bring new therapies to market. I'm particularly interested in roles where I can lead commercial strategy and execution for launch or near-launch assets.

Pharma Launch Excellence Summit Conference Day 1: Wednesday September 30

2:30 PM Panel Discussion: From US Price Pressure to Global Launch Strategy: Rethinking Where, When and How to Launch

US pricing pressure is no longer a domestic market access issue, it is reshaping global launch strategy. As pharma leaders face uncertainty around price reform, transparency, payer pressure, PBM dynamics and the potential global implications of reduced US pricing power, launch teams are being forced to rethink where, when and how they bring products to market.

This panel will explore how commercial, access and global launch leaders are adapting launch strategy in an environment where profitability assumptions, sequencing decisions and market prioritization are becoming harder to predict.

• Assessing how US pricing pressure could reshape global launch sequencing

• Balancing patient access, profitability and market prioritization under uncertainty

• Adapting launch strategy when oncology and specialty markets become more fragmented

• Building flexible launch plans for narrower indications and smaller patient populations

Pharma Launch Excellence Summit Conference Day 2: Thursday October 1

9:00 AM Morning Presentation / Case Study: From Search to Start: How AI-Informed Patients Are Reshaping Launch

Patients are no longer only arriving at treatment conversations informed by websites, adverts or advocacy groups. Increasingly, they are using AI search, symptom tools, social content and digital health platforms to understand conditions, compare treatments and shape the questions they bring to HCPs. For launch teams, this changes the dynamics of demand generation, education, access and adherence, especially in high-cost, specialty and consumer-visible categories.

Drawing on Julie's experience across US Market Access, specialty pharma, sales, marketing, advocacy and enterprise strategy, this session will explore how AI-influenced patient behavior is reshaping launch planning, and why access, medical, commercial and patient engagement teams need to respond together.

• Understanding how AI is changing patient awareness, expectations and decision-making

• Connecting patient demand, HCP engagement and access strategy earlier

• Managing affordability and reimbursement friction as patient interest grows

• Building launch plans that account for consumer empowerment and misinformation risk

Check out the incredible speaker line-up to see who will be joining Julie.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk